Evolent Health (EVH) PT Lowered to $48 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Richard Close lowered the price target on Evolent Health (NYSE: EVH) to $48.00 (from $55.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
